SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-111804
Filing Date
2024-10-28
Accepted
2024-10-28 16:02:18
Documents
4
Period of Report
2024-11-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2426173-2_def14a.htm DEF 14A 247558
2 GRAPHIC lg_transcodetheraptm-4c.jpg GRAPHIC 10112
3 GRAPHIC px_24transcodepg01-bw.jpg GRAPHIC 260337
4 GRAPHIC px_24transcodepg02-bw.jpg GRAPHIC 227384
  Complete submission text file 0001104659-24-111804.txt   874607
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40363 | Film No.: 241400849
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)